The estimated Net Worth of Paul Bolno is at least $8.38 Million dollars as of 21 August 2024. Paul Bolno owns over 48,366 units of Wave Life Sciences stock worth over $2,118,448 and over the last 8 years he sold WVE stock worth over $2,682,484. In addition, he makes $3,581,530 as President, Chief Executive Officer und Director at Wave Life Sciences.
Sign up
Paul Bolno WVE stock SEC Form 4 insiders trading
Paul has made over 14 trades of the Wave Life Sciences stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 48,366 units of WVE stock worth $279,555 on 21 August 2024.
The largest trade he's ever made was selling 147,577 units of Wave Life Sciences stock on 2 July 2020 worth over $1,520,043. On average, Paul trades about 21,158 units every 91 days since 2016. As of 21 August 2024 he still owns at least 359,059 units of Wave Life Sciences stock.
You can see the complete history of Paul Bolno stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Paul Bolno biography
Dr. Paul B. Bolno M.D. serves as President, Chief Executive Officer, Director of the Company. Prior to joining us, he served at GlaxoSmithKline from 2009 to 2013 in various roles, including Vice President, Worldwide Business Development—Head of Asia BD and Investments, Head of Global Neuroscience BD, a director of Glaxo Welcome Manufacturing, Pte. Ltd. in Singapore and Vice President, Business Development for the Oncology Business Unit, where he helped establish GlaxoSmithKline’s global oncology business and served as a member of the Oncology Executive Team, Oncology Commercial Board and Cancer Research Executive Team. Prior to GlaxoSmithKline, he served as director of Research at Two River LLC, a health care private equity firm from 2004 to 2009. Dr. Bolno earned a medical degree from MCP-Hahnemann School of Medicine and an M.B.A. from Drexel University. He was a general surgery resident and cardiothoracic surgery postdoctoral research fellow at Drexel University College of Medicine.
What is the salary of Paul Bolno?
As the President, Chief Executive Officer und Director of Wave Life Sciences, the total compensation of Paul Bolno at Wave Life Sciences is $3,581,530. There are no executives at Wave Life Sciences getting paid more.
How old is Paul Bolno?
Paul Bolno is 46, he's been the President, Chief Executive Officer und Director of Wave Life Sciences since 2014. There are 13 older and 5 younger executives at Wave Life Sciences. The oldest executive at Wave Life Sciences Ltd. is Koji Miura, 71, who is the Independent Director.
What's Paul Bolno's mailing address?
Paul's mailing address filed with the SEC is C/O WAVE LIFE SCIENCES LTD.,, 733 CONCORD AVE., CAMBRIDGE, MA, 02138.
Insiders trading at Wave Life Sciences
Over the last 9 years, insiders at Wave Life Sciences have traded over $19,158,839 worth of Wave Life Sciences stock and bought 18,619,108 units worth $128,204,225 . The most active insiders traders include Plc Gsk, Capital Management, L.P.Ra ... und Capital Management, Llc Kol.... On average, Wave Life Sciences executives and independent directors trade stock every 43 days with the average trade being worth of $1,569,819. The most recent stock trade was executed by Paul Bolno on 21 August 2024, trading 48,366 units of WVE stock currently worth $279,555.
What does Wave Life Sciences do?
wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.
What does Wave Life Sciences's logo look like?
Complete history of Paul Bolno stock trades at Wave Life Sciences und SQZ Biotechnologies Co
Wave Life Sciences executives and stock owners
Wave Life Sciences executives and other stock owners filed with the SEC include:
-
Paul Bolno,
President, Chief Executive Officer, Director -
Christopher Francis,
Senior Vice President - Corporate Development, Head of Emerging Areas -
Michael Panzara,
Chief Medical Officer -
Chandra Vargeese,
Senior Vice President, Head of Drug Discovery -
Dr. Paul B. Bolno M.B.A., M.D., MBA,
Pres, CEO & Director -
Dr. Michael A. Panzara M.D., M.P.H., MPH,
Chief Medical Officer and Head of Therapeutics Discovery & Devel. -
Dr. Chandra Vargeese Ph.D.,
Chief Technology Officer -
Gregory Verdine,
Director -
Mark Corrigan,
Independent Director -
Amy Pott,
Independent Director -
Heidi Wagner,
Independent Director -
Christian Henry,
Independent Chairman of the Board -
Peter Kolchinsky,
Independent Director -
Ken Takanashi,
Independent Director -
Adrian Rawcliffe,
Independent Director -
Koji Miura,
Independent Director -
Kenneth Rhodes,
Senior Vice President - Therapeutics Discovery -
David Gaiero,
Interim Chief Financial Officer -
Kate Rausch,
Investor Relations -
Anne-Marie Li-Kwai-Cheung,
Sr. VP of Regulatory Affairs, Compliance & Policy -
Dr. Sridhar Vaddeboina Ph.D.,
Sr. VP of Chemistry, Manufacturing & Controls -
Jose Juves,
Sr. VP of Corp. Affairs & Patient Advocacy -
Jonathan Rosin,
Chief HR Officer -
Dr. Christopher Francis Ph.D.,
Sr. VP of Corp. Devel. & Head of Emerging Areas -
Linda Rockett J.D.,
Gen. Counsel -
Kyle B. Moran CFA,
CFO & Principal Accounting Officer -
Chris Francis,
See Remarks -
Plc Gsk,
10% owner -
Keith Regnante,
Chief Financial Officer -
Takeshi Wada,
Director -
Ken Shin Nippon Biomedical ...,
-
Masaharu Kagoshima Shinsang...,
-
Roberto Guerciolini,
See Remarks -
Masaharu Tanaka,
Director -
Peter Kolchinsky,
Director -
Capital Management, Llc Kol...,
-
Mark Baldry,
Chief Commerical Officer -
Capital Management, L.P.Ra ...,
-
Kyle Moran,
Chief Financial Officer -
Aik Na Tan,